Antiplatelet therapy for peripheral artery disease

Area of Science:

• Cardiovascular Medicine
• Vascular Surgery
• Pharmacology

Background:

• Atherosclerotic cardiovascular disease is a leading cause of mortality and morbidity.
• Peripheral arterial diseases (PADs), including lower extremity artery disease (LEAD) and carotid artery disease, increase cardiovascular event risk.
• Optimal antiplatelet therapy is critical for PAD patients, yet data are limited and often extrapolated from coronary artery disease studies.

Purpose of the Study:

• To review current evidence on antiplatelet treatment in patients with LEAD and carotid stenosis.
• To provide evidence-based guidance for clinical decision-making in managing these high-risk patients.

Main Methods:

• Systematic review of registries, randomized trials, and meta-analyses.
• Focus on antiplatelet treatment strategies in patients with lower extremity artery disease and carotid stenosis.

Main Results:

• Analysis of existing data on antiplatelet efficacy and safety in PAD populations.
• Identification of gaps in knowledge regarding optimal antiplatelet regimens.

Conclusions:

• Evidence supports the need for optimized antiplatelet strategies in PAD patients.
• Further research is required to establish definitive guidelines for antiplatelet therapy in LEAD and carotid stenosis.